Vext to Announce Financial Results for Q4 and Fiscal 2024 on March 31, 2025
Vext Science (CSE: VEXT, OTCQX: VEXTF), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, has scheduled its Q4 and fiscal 2024 financial results announcement for March 31, 2025, before market open.
The company will host a conference call and webcast on the same day at 8:00 AM ET to discuss the quarterly and full-year 2024 results. Participants can join via phone using dial-in numbers +1-647-849-3159 or 1-833-752-3966 (Conference ID: 10197749). A replay will be available until April 14, 2025, using playback number 5786741.
Vext Science (CSE: VEXT, OTCQX: VEXTF), un operatore di cannabis con sede negli Stati Uniti e operazioni verticali in Arizona e Ohio, ha programmato l'annuncio dei risultati finanziari per il quarto trimestre e l'anno fiscale 2024 per 31 marzo 2025, prima dell'apertura del mercato.
La società ospiterà una conferenza telefonica e una trasmissione in diretta lo stesso giorno alle 8:00 AM ET per discutere i risultati trimestrali e dell'intero anno 2024. I partecipanti possono unirsi telefonicamente utilizzando i numeri +1-647-849-3159 o 1-833-752-3966 (ID conferenza: 10197749). Una registrazione sarà disponibile fino al 14 aprile 2025, utilizzando il numero di riproduzione 5786741.
Vext Science (CSE: VEXT, OTCQX: VEXTF), un operador de cannabis con sede en EE. UU. y operaciones verticales en Arizona y Ohio, ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año fiscal 2024 para el 31 de marzo de 2025, antes de la apertura del mercado.
La empresa llevará a cabo una conferencia telefónica y una transmisión en vivo el mismo día a las 8:00 AM ET para discutir los resultados trimestrales y del año completo 2024. Los participantes pueden unirse por teléfono utilizando los números +1-647-849-3159 o 1-833-752-3966 (ID de la conferencia: 10197749). Una grabación estará disponible hasta el 14 de abril de 2025, utilizando el número de reproducción 5786741.
Vext Science (CSE: VEXT, OTCQX: VEXTF)는 미국에 본사를 둔 대마초 운영업체로 아리조나와 오하이오에서 수직 운영을 하고 있으며, 2025년 3월 31일에 4분기 및 2024 회계연도 재무 결과 발표를 예정하고 있습니다. 시장 개장 전입니다.
회사는 같은 날 오전 8시 ET에 분기 및 전체 연도 2024 결과를 논의하기 위해 전화 회의 및 웹캐스트를 개최합니다. 참가자는 전화로 +1-647-849-3159 또는 1-833-752-3966 (회의 ID: 10197749)로 참여할 수 있습니다. 재생 번호 5786741을 사용하여 2025년 4월 14일까지 다시 들을 수 있습니다.
Vext Science (CSE: VEXT, OTCQX: VEXTF), un opérateur de cannabis basé aux États-Unis avec des opérations verticales en Arizona et dans l'Ohio, a programmé l'annonce de ses résultats financiers du quatrième trimestre et de l'exercice 2024 pour le 31 mars 2025, avant l'ouverture des marchés.
La société organisera une conférence téléphonique et un webinaire le même jour à 8h00 ET pour discuter des résultats trimestriels et de l'année complète 2024. Les participants peuvent se joindre par téléphone en utilisant les numéros +1-647-849-3159 ou 1-833-752-3966 (ID de conférence : 10197749). Un enregistrement sera disponible jusqu'au 14 avril 2025, en utilisant le numéro de lecture 5786741.
Vext Science (CSE: VEXT, OTCQX: VEXTF), ein in den USA ansässiger Cannabis-Betreiber mit vertikalen Operationen in Arizona und Ohio, hat die Bekanntgabe seiner finanziellen Ergebnisse für das vierte Quartal und das Geschäftsjahr 2024 auf den 31. März 2025 vor Markteröffnung angesetzt.
Das Unternehmen wird am selben Tag um 8:00 AM ET eine Telefonkonferenz und einen Webcast abhalten, um die Quartals- und Jahresergebnisse 2024 zu besprechen. Teilnehmer können sich telefonisch unter den Nummern +1-647-849-3159 oder 1-833-752-3966 (Konferenz-ID: 10197749) einwählen. Eine Aufzeichnung wird bis zum 14. April 2025 unter der Wiedergabenummer 5786741 verfügbar sein.
- None.
- None.
Vancouver, British Columbia--(Newsfile Corp. - March 19, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it plans to release its financial results for the period ended December 31, 2024, before market open on March 31, 2025.
The Company will host a conference call and webcast on the same day, Monday, March 31, 2025, at 08:00 a.m. ET to discuss the financial results for the fourth quarter and full year 2024.
CONFERENCE CALL DETAILS
Date: March 31, 2025 | Time: 8:00 am E.T.
Participant Dial-in: +1-647-849-3159 or 1-833-752-3966
Replay Dial-in: +1-412-317-0088 or 1-855-669-9658
Conference ID: 10197749
Playback #: 5786741 (Expires on April 14, 2025)
Listen to webcast: https://www.gowebcasting.com/13994
A replay of the conference call and webcast will be available on Vext's investor website following the conclusion of the call. For more details, contact the IR team at investors@vextscience.com.
About Vext Science, Inc.
Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. Vext's expertise spans from cultivation through to retail operations in its key markets. Based out of Arizona, Vext owns and operates state-of-the-art cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company manufactures Vapen™, one of the leading THC concentrates, edibles, and distillate cartridge brands in Arizona. Its selection of award-winning products are created with Vext's in-house, high-quality flower and distributed across Arizona and Ohio. Vext's leadership team brings a proven track record of building and operating profitable multi-state operations, with the Company having operated profitably since 2016. The Company's primary focus is to continue growing in its core states of Arizona and Ohio, bringing together cutting-edge science, manufacturing, and marketing to provide a reliable and valuable customer experience while generating shareholder value.
Vext Science, Inc. is listed on the Canadian Securities Exchange under the symbol VEXT and trades on the OTCQX market under the symbol VEXTF. Learn more at www.vextscience.com and connect with Vext on Twitter/X and LinkedIn.
For more details on the Vapen brand:
Vapen website: VapenBrands.com
Instagram: @vapen
Facebook: @vapenbrands
Forward-Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Vext's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding the expected filing date of the financial results, future developments and the business and operations of the Vext, all of which are subject to the risk factors contained in Vext's continuous disclosure filed on SEDAR+ at www.sedarplus.ca.
Although Vext has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; being engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindered market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Vext disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Vext does not assume any liability for disclosure relating to any other company mentioned herein.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Eric Offenberger
Chief Executive Officer
844-211-3725
For further information:
Jonathan Ross, Vext Investor Relations
jon.ross@loderockadvisors.com
416-244-9851
SOURCE: Vext Science, Inc
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/244414